Reports of Biochemistry and Molecular Biology

Scope & Guideline

Connecting researchers with groundbreaking discoveries.

Introduction

Welcome to your portal for understanding Reports of Biochemistry and Molecular Biology, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN2322-3480
PublisherVARASTEGAN INST MEDICAL SCIENCES
Support Open AccessYes
CountryIran
TypeJournal
Convergefrom 2017 to 2024
AbbreviationREP BIOCHEM MOL BIOL / Rep. Biochem. Mol. Biol.
Frequency2 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address3 LADAN ST, VAKIL-ABAD BLVD, P O 9179667680, MASHHAD 00000, IRAN

Aims and Scopes

Reports of Biochemistry and Molecular Biology aims to advance knowledge in the fields of biochemistry and molecular biology through innovative research and comprehensive reviews.
  1. Biomarkers and Disease Correlation:
    The journal focuses on the identification and validation of biomarkers for various diseases, exploring their roles in diagnosis, prognosis, and treatment outcomes.
  2. Molecular Mechanisms in Cancer:
    Research on the molecular mechanisms underlying cancer progression, treatment responses, and the development of novel therapeutic strategies is a core theme.
  3. Genetic and Epigenetic Studies:
    Studies investigating genetic polymorphisms, gene expression, and epigenetic modifications related to disease susceptibility and progression, particularly in cancer, are prevalent.
  4. Oxidative Stress and Inflammation:
    The journal includes research on the roles of oxidative stress and inflammatory processes in various diseases, emphasizing their biochemical mechanisms and potential therapeutic targets.
  5. Nanotechnology in Medicine:
    Innovative applications of nanotechnology in drug delivery and therapeutic interventions are explored, highlighting their potential in enhancing treatment efficacy.
  6. MicroRNA and Non-Coding RNAs:
    The role of microRNAs and long non-coding RNAs in disease mechanisms and their potential as therapeutic targets or biomarkers is a significant focus.
Recent publications reflect emerging themes and trends that indicate the evolving focus of the journal.
  1. Personalized Medicine and Pharmacogenomics:
    There is a growing emphasis on personalized medicine, particularly studies that explore the genetic basis of drug responses and individual treatment plans.
  2. Role of Non-Coding RNAs in Disease:
    Research on the functional roles of non-coding RNAs, especially microRNAs, in various diseases has surged, indicating their potential as biomarkers and therapeutic targets.
  3. Impact of Environmental Factors on Health:
    Emerging studies linking environmental exposures (e.g., pollutants, dietary components) to biochemical changes and disease mechanisms highlight the relevance of environmental health.
  4. Innovative Therapeutics and Drug Delivery Systems:
    There is an increasing focus on novel therapeutic strategies, particularly those involving nanotechnology and advanced drug delivery systems, demonstrating innovation in treatment approaches.
  5. Systems Biology and Multi-Omics Approaches:
    The integration of systems biology and multi-omics approaches in understanding complex biological systems and diseases is gaining traction, reflecting a holistic view of health.

Declining or Waning

While certain themes have gained traction, others appear to be declining in prominence within the journal's recent publications.
  1. Traditional Biochemical Methods:
    Research employing classical biochemical techniques without integration of modern molecular biology approaches has seen a decline, as the field moves towards more advanced methodologies.
  2. Non-Specific Dietary Studies:
    Studies focused solely on non-specific dietary impacts on health without molecular or biochemical mechanisms are less frequent, suggesting a shift towards more mechanistic research.
  3. Animal Models in Isolation:
    Research utilizing animal models without clear translational implications to human health or disease mechanisms is becoming less common, as the journal emphasizes relevance to human health.

Similar Journals

GENE

Unveiling Innovations in Genetics and Medicine
Publisher: ELSEVIERISSN: 0378-1119Frequency: 48 issues/year

GENE, an esteemed journal published by Elsevier, serves as a vital resource for researchers and professionals in the fields of genetics and medicine. With an ISSN of 0378-1119 and an E-ISSN of 1879-0038, this scholarly journal has been at the forefront of genetic research since its inception in 1976 and is set to continue until 2025. Situated in the Netherlands, GENE is recognized for its significant contributions, reflected in its Q2 ranking in both Genetics and Miscellaneous Medicine categories for 2023. This positioning within the Scopus rankings demonstrates its impact and relevance in a competitive field, where it holds the rank of #129 out of 347 in Genetics, placing it within the 62nd percentile. Although it does not offer open access options, GENE provides invaluable insight into contemporary genetic research, thereby fostering academic discussions and advancements. Researchers, professionals, and students alike will find GENE an essential platform for disseminating knowledge and exploring innovative developments in genetics and associated sciences.

CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY

Unveiling Critical Perspectives in Biochemistry
Publisher: TAYLOR & FRANCIS LTDISSN: 1040-9238Frequency: 6 issues/year

Welcome to Critical Reviews in Biochemistry and Molecular Biology, a premier academic journal published by Taylor & Francis Ltd, dedicated to advancing the fields of biochemistry and molecular biology. With an impressive impact factor and a Q1 ranking in both Biochemistry and Molecular Biology for 2023, this journal serves as a vital resource for researchers, professionals, and students eager to engage with cutting-edge reviews and analyses that synthesize the latest developments in these dynamic areas of study. Since its inception in 1972, the journal has maintained a commitment to high-quality scholarship, providing a platform for critical discussions that accelerate the discovery and understanding of biochemical processes and molecular interactions. Although not open access, its robust editorial peer-review process ensures that published articles meet the highest standards of scientific rigor, making it a trusted source for the scientific community. As we continue to converge toward 2024, we invite you to explore the extensive array of topics and findings that have shaped contemporary biochemistry and molecular biology.

JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY

Illuminating the Pathways of Biochemical and Molecular Science
Publisher: WILEYISSN: 1095-6670Frequency: 12 issues/year

Journal of Biochemical and Molecular Toxicology, published by Wiley, plays a pivotal role in the advancement of knowledge within the fields of biochemistry, toxicology, and molecular biology. Established in 1998, this esteemed journal has garnered a significant reputation, evidenced by its current placement in the Q2 quartile across several categories, including Biochemistry, Health, Toxicology and Mutagenesis, and Medicine. With an ISSN of 1095-6670 and an E-ISSN of 1099-0461, it serves an international audience, offering critical insights and innovative research that shape our understanding of biochemical interactions and toxicological assessments. While it does not operate on an open-access model, the journal ensures rigorous peer review and high-quality publication standards, making it a valuable resource for researchers, professionals, and students dedicated to the exploration of molecular toxicology. The journal's recognized impact within the scientific community is reflected in its competitive rankings among specialized journals, fostering significant contributions to both academic and applied contexts.

Biochemistry and Biophysics Reports

Elevating the discourse in biochemistry and biophysics.
Publisher: ELSEVIERISSN: 2405-5808Frequency: 4 issues/year

Biochemistry and Biophysics Reports, published by Elsevier, serves as a vital platform for the dissemination of innovative research in the fields of biochemistry, biophysics, cell biology, and molecular biology. With an Open Access model initiated in 2015, this journal aims to facilitate the unimpeded sharing of knowledge, allowing researchers, professionals, and students free access to significant findings and developments. The journal has established a presence in the academic community, currently holding a Q3 ranking in Biochemistry, Q2 in Biophysics, alongside its Q3 standings in both Cell Biology and Molecular Biology categories for 2023. These metrics underscore its commitment to quality and relevance, garnering attention with Scopus ranks reflecting its emerging influence. Located in the Netherlands, Biochemistry and Biophysics Reports continues to foster dialogue and collaboration among the scientific community through high-quality research outputs, contributing to advancements in understanding the intricate biochemical processes and biophysical principles that underpin life sciences.

Aging-US

Elevating Conversations in Aging and Cell Biology
Publisher: IMPACT JOURNALS LLCISSN: 1945-4589Frequency: 24 issues/year

Aging-US is a premier peer-reviewed journal dedicated to advancing the field of aging research and cell biology. Published by IMPACT JOURNALS LLC, this journal serves as a vital resource for researchers and professionals exploring the biological mechanisms of aging and their implications for health and disease. With a commendable impact factor reflected in its 2023 Scopus rankings, where it stands at Rank #10/38 in the category of Aging and Rank #63/285 in Cell Biology, Aging-US exemplifies rigorous scientific excellence. Its open access policy enhances accessibility, fostering a wider dissemination of knowledge in both academic and clinical settings. Spanning from 2009 to 2024, the journal provides a platform for groundbreaking studies and innovative methodologies, ensuring that it remains at the forefront of the dynamic conversations surrounding aging and cellular biology. Engage with Aging-US to contribute to the evolving narratives of longevity and cellular health.

CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Unleashing Innovations in Physiology and Biochemistry
Publisher: Cell Physiol Biochem Press GmbH & CoISSN: 1015-8987Frequency: 6 issues/year

Cellular Physiology and Biochemistry is a premier Open Access journal published by the prestigious Cell Physiol Biochem Press GmbH & Co, dedicated to advancing research in the fields of physiology, biochemistry, and molecular biology. Since its inception in 1987 and transitioning to an Open Access model in 2013, the journal has established itself as a vital resource for the dissemination of high-quality research and reviews, showcasing innovative methodologies and groundbreaking findings in cellular processes. With an impressive ranking in the 2023 Scopus category as Q2 in Physiology and a robust percentile of 61, Cellular Physiology and Biochemistry is committed to fostering academic dialogue among researchers, professionals, and students alike. This journal not only provides unrestricted access to its articles, but also promotes the global sharing of knowledge, which is essential for the advancement of our understanding in these vital scientific areas. The journal's editorial team is dedicated to ensuring the highest standards of academic rigor and relevance, making it an indispensable addition to the libraries of those engaged in the life sciences.

MOLECULAR AND CELLULAR BIOCHEMISTRY

Fostering Innovation in Cellular Biochemistry
Publisher: SPRINGERISSN: 0300-8177Frequency: 12 issues/year

MOLECULAR AND CELLULAR BIOCHEMISTRY, an esteemed journal published by SPRINGER, serves as a prominent platform in the fields of biochemistry and molecular biology. With a history of dissemination since 1973, this journal has made significant contributions to the understanding of biochemical processes at the molecular level. The MOLECULAR AND CELLULAR BIOCHEMISTRY journal focuses on a myriad of topics including but not limited to cellular biochemistry, clinical biochemistry, and interdisciplinary approaches in medicine, boasting a commendable categorization in the 2023 Scopus ranks where it falls under Q3 in Cell Biology, Q2 in Clinical Biochemistry, Q1 in Medicine (miscellaneous), and Q2 in Molecular Biology. Although the journal is not open access, it provides access options through institutional subscriptions, making valuable research accessible to a wider audience. With its rigorous peer-review process and high impact within the scientific community, this journal aims to advance knowledge and stimulate exploration in biochemical research, making it essential reading for researchers, professionals, and students alike.

Epigenetics

Catalyzing Discoveries in Medicine and Molecular Biology
Publisher: TAYLOR & FRANCIS INCISSN: 1559-2294Frequency: 12 issues/year

Epigenetics, published by Taylor & Francis Inc, is a leading journal in the fields of Cancer Research, Medicine (miscellaneous), and Molecular Biology. With an ISSN of 1559-2294 and an E-ISSN of 1559-2308, this journal has been paving the way for groundbreaking research since its inception in 2006, and it continues to play a crucial role in advancing our understanding of epigenetic mechanisms and their implications in health and disease. The journal is highly regarded, ranking in the Q1 category for Medicine and Q2 for both Cancer Research and Molecular Biology according to the 2023 category quartiles. Researchers and professionals in the field will find invaluable insights and innovative studies within its pages, making it an essential resource for those engaged in cutting-edge research. Although the journal is not open access, it encourages a comprehensive understanding through high-quality peer-reviewed content. With its creative exploration of the epigenetic landscape, Epigenetics serves as a vital platform for the sharing of knowledge that could lead to breakthroughs in treatments and therapies.

Biochemistry Research International

Fostering innovation in biochemistry through open access research.
Publisher: HINDAWI LTDISSN: 2090-2247Frequency: 1 issue/year

Biochemistry Research International is a prominent and dynamic journal published by Hindawi Ltd, dedicated to advancing knowledge in the field of biochemistry. With its Open Access model established since 2010, the journal provides unrestricted access to high-quality research, thereby fostering global communication among researchers and professionals. Operating out of the United States, Biochemistry Research International serves as a vital platform for disseminating cutting-edge findings in biochemistry and molecular biology, holding a respectable Q2 ranking in its category as of 2023. The journal's scope encompasses a wide array of topics including but not limited to biochemical processes, genetic engineering, and molecular interactions, making it an essential resource for students and seasoned researchers alike. With an impact factor reflective of its significance in the academic community, Biochemistry Research International continues to play an integral role in shaping the future of biochemistry research.

Molecular Cancer

Pioneering open access to vital cancer insights.
Publisher: BMCISSN: Frequency: 1 issue/year

Molecular Cancer, published by BMC, stands as a premier open access journal dedicated to advancing our understanding of cancer biology, treatment, and prevention since its inception in 2002. With an impressive Q1 ranking in the domains of Cancer Research, Molecular Medicine, and Oncology, this journal occupies a significant position in the academic landscape, emphasizing high-quality research that influences clinical practices and future studies. The journal is indexed in leading databases with exceptional Scopus ranks, reflecting its rigorous peer-review process and impactful contributions to the field, where it ranks in the top 2-3 positions across various relevant categories. Based in the United Kingdom, Molecular Cancer offers researchers worldwide a valuable platform for disseminating innovative findings that drive the biomedical community forward. The journal's open access model ensures that groundbreaking research is freely accessible, fostering collaboration and knowledge sharing among professionals, students, and academics alike. Explore cutting-edge developments in cancer research through Molecular Cancer and join a community committed to improving patient outcomes and advancing scientific discovery.